According to VectivBio's latest financial reports the company's total assets are $0.25 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $0.25 B | 85.01% |
2021-12-31 | $0.13 B | 93.49% |
2020-12-31 | $70.56 M | 60.72% |
2019-12-31 | $43.9 M | 84.32% |
2018-12-31 | $23.81 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Organovo ONVO | $8.88 M | -96.48% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.20 B | -19.93% | ๐ฌ๐ง UK |
Novavax NVAX | $1.79 B | 611.60% | ๐บ๐ธ USA |
Novocure
NVCR | $1.14 B | 353.73% | Jersey |